4.4 Article

The role of Bax-inhibiting peptide in retinal ganglion cell apoptosis after optic nerve transection

Journal

NEUROSCIENCE LETTERS
Volume 372, Issue 1-2, Pages 17-21

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.neulet.2004.08.075

Keywords

apoptosis; Bax; Bax-inhibiting peptide; retinal ganglion cells; optic nerve transection

Categories

Funding

  1. NEI NIH HHS [EY11295] Funding Source: Medline

Ask authors/readers for more resources

Bax, a pro-apoptotic member of Bcl-2 family proteins, plays a central role in mitochondria-dependent apoptosis. Bax normally resides in the cytosol in a quiescent state. Bax-inhibiting peptide (BIP) is a membrane permeable peptide comprised of five amino acids designed from the Bax-binding domain of Ku70 [M. Sawada, P. Hayes, S. Matsuyama, Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70, Nat. Cell Biol. 5 (2003) 352-357]. It inhibits Bax-mediated translocation of cytochrome c and suppresses mitochondria-dependent apoptosis. BIP was used in order to elucidate its role in preventing retinal ganglion cell (RGC) death from apoptosis after optic nerve transection (ONT) in adult Wistar rats. RGC survival was significantly higher in animals with intravitreal injection of BIP, when compared with control animals. These findings suggest that BIP prevented RGC apoptosis after ONT prompting the suggestion that Bax plays a central role in RGC apoptosis after ONT. (C) 2004 Elsevier Ireland Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available